Morphine for the relief of breathlessness in patients with chronic heart failure - a pilot study

被引:153
作者
Johnson, MJ
McDonagh, TA
Harkness, A
McKay, SE
Dargie, HJ
机构
[1] W Scotland Rotat, Glasgow, Lanark, Scotland
[2] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland
[3] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland
[4] Huntershill Marie Curie Ctr, Glasgow, Lanark, Scotland
关键词
morphine; breathlessness; heart failure; palliative care;
D O I
10.1016/S1388-9842(02)00158-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic heart failure (CHF) patients can experience significant breathlessness despite maximum medication for their heart failure. Morphine has long been used to relieve symptoms in acute failure, but there is little evidence about this potentially useful palliative therapy in CHF. Aims: To determine the efficacy of morphine for the relief of breathlessness in patients with CHF. Method: Ten out-patients with NYHA III/IV CHF entered a randomised, double-blind, placebo controlled, crossover pilot study The active ann was 4 days of 5 mg oral morphine four times daily (2.5 mg morphine if creatinine >200 mumol/l). There were 2 days wash-out between active and placebo arms. Results: 6/10 patients indicated that morphine improved their breathlessness. On morphine, the median breathlessness score fell by 23 mm (P=0.022) by day 2. The improvement was maintained. Sedation scores increased until day 3 (P=0.013), reducing on day 4. Four patients developed constipation (P= 0.026). On placebo, there was no significant difference in breathlessness or sedation. One patient had constipation. There were no significant differences in either arm in nausea, quality of life scores, blood pressure, pulse, respiratory rate, or catecholamines. Brain natriuretic peptide fell in both arms; significantly in the morphine arm. Conclusion: Morphine relieves breathlessness due to CHF. A larger study is indicated. (C) 2002 European Society of Cardiology. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:753 / 756
页数:4
相关论文
共 11 条
[1]   SMALL NUMBERS OF PATIENTS WITH TERMINAL CARDIAC-FAILURE MAY MAKE CONSIDERABLE DEMANDS ON SERVICES [J].
BEATTIE, JM ;
MURRAY, RG ;
BRITTLE, J ;
CATANHEIRA, T .
BRITISH MEDICAL JOURNAL, 1995, 310 (6991) :1411-1411
[2]   Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure [J].
Chua, TP ;
Harrington, D ;
Ponikowski, P ;
WebbPeploe, K ;
PooleWilson, PA ;
Coats, AJS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (01) :147-152
[3]   PALLIATIVE CARE IN SEVERE HEART-FAILURE [J].
CUSHEN, M .
BRITISH MEDICAL JOURNAL, 1994, 308 (6930) :717-717
[4]  
Department of Health, NAT SERV FRAM COR HE
[5]   CASE-STUDIES OUTLINING USE OF NEBULIZED MORPHINE FOR PATIENTS WITH END-STAGE CHRONIC LUNG AND CARDIAC DISEASE [J].
FARNCOMBE, M ;
CHATER, S .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1993, 8 (04) :221-225
[6]   Chronic heart failure and morphine treatment [J].
Fischer, MD .
MAYO CLINIC PROCEEDINGS, 1998, 73 (02) :194-194
[7]   PALLIATIVE CARE IN TERMINAL CARDIAC-FAILURE [J].
JONES, S .
BRITISH MEDICAL JOURNAL, 1995, 310 (6982) :805-805
[8]  
McCarthy M, 1996, J ROY COLL PHYS LOND, V30, P325
[9]   Biochemical detection of left-ventricular systolic dysfunction [J].
McDonagh, TA ;
Robb, SD ;
Murdoch, DR ;
Morton, JJ ;
Ford, I ;
Morrison, CE ;
Tunstall-Pedoe, H ;
McMurray, JJV ;
Dargie, HJ .
LANCET, 1998, 351 (9095) :9-13
[10]  
WILLIAMS SG, 2001, HEART, V85, P4